The gap between Brent futures and WTI futures narrowed after Brent prices slipped on news that one of Scotland's largest refineries would remain open despite rumors that it would close. Brent traded at $107.15 at 4:50 GMT on Monday morning as confidence returned to WTI.
US crude has recently been under pressure as a seasonal lack of demand coupled with domestic oil production has caused a sharp and unexpected increase in stockpiles. The Energy Information Administration surprised investors when it released a report which showed US stockpiles had jumped last week, causing WTI prices to plummet.
Related: #PreMarket Primer: Monday, October 28: All Eyes On Apple
Oil prices have also been shouldering the burden of the US' political struggle to agree on a budget for the upcoming year. After shutting down for more than two weeks, the US government has reopened, but not without fallout from the showdown.
10 Best Growth Stocks For 2015: Take-Two Interactive Software Inc.(TTWO)
Take-Two Interactive Software, Inc. publishes, develops, and distributes interactive entertainment software, hardware, and accessories worldwide. The company develops and publishes software titles for various gaming and entertainment hardware platforms, including PlayStation3 and PlayStation2 computer entertainment systems, PlayStation Portable system, Xbox 360 video game and entertainment system, and Wii and DS systems, as well as for the personal computer and games for Windows. It offers products through its wholly owned labels Rockstar Games and 2K, which publishes titles under 2K Games, 2K Sports, and 2K Play. The company, through its subsidiary, Jack of All Games, also distributes software, hardware, and accessories in North America. Its proprietary brand franchises include Grand Theft Auto; Sid Meier's Civilization; Max Payne; Midnight Club; Manhunt; Red Dead Revolver; Bully; BioShock; Sid Meier's Railroads!; Sid Meier's Pirates!; Carnival Games; and Top Spin, as wel l as licensed brands comprise the sports games Major League Baseball 2K; NBA 2K; and NHL 2K. The company sells its software titles to retail outlets through direct relationships with large retail customers and third party distributors. Its customers include mass merchandisers, specialty retailers, video stores, electronics stores, toy stores, national and regional drug stores, and supermarket and discount store chains. The company was founded in 1993 and is headquartered in New York, New York.
Advisors' Opinion:- [By Monica Gerson]
Take-Two Interactive Software (NASDAQ: TTWO) is expected to post its Q4 earnings at $0.10 per share on revenue of $202.51 million.
CTI Industries (NASDAQ: CTIB) is estimated to report its Q1 earnings at $0.02 per share on revenue of $15.75 million.
- [By Ashraf Eassa]
In the earnings preview for Take-Two Interactive (NASDAQ: TTWO ) published ahead of earnings, one of the chief concerns I had was that analyst expectations may have been too aggressive. Indeed, with analyst consensus sitting at the high end of Take-Two's full-year guidance, there was risk of investor disappointment if the company didn't guide upward.
- [By Demitrios Kalogeropoulos]
Take-Two Interactive (NASDAQ: TTWO ) had a much better 2013 than its rival video game publishers. But you wouldn't know that by comparing the companies' stocks. Despite massively outperforming profit and sales expectations -- and releasing the year's biggest game in Grand Theft Auto V --�Take-Two is trailing industry giants�Electronic Arts (NASDAQ: EA ) and Activision Blizzard (NASDAQ: ATVI ) . So what does the company need to do to finally win some respect from Wall Street?
Top 5 Dow Dividend Stocks To Watch Right Now: LDK Solar Co. Ltd.(LDK)
LDK Solar Co., Ltd., together with its subsidiaries, engages in the design, development, manufacture, and marketing of photovoltaic (PV) products; and development of power plant projects. It offers solar-grade and semiconductor-grade polysilicon; and multicrystalline and monocrystalline solar wafers to the manufacturers of solar cells and solar modules. The company also provides wafer processing services to monocrystalline and multicrystalline solar cell and module manufacturers; and sells silicon materials, such as ingots and polysilicon scraps. In addition, it engages in the production and sale of solar cells and modules to developers, distributors, and system integrators; and design and development of solar power projects in Europe, the United States, and China, as well as provides engineering, procurement, and construction services. LDK Solar Co., Ltd. operates in Europe, the Asia Pacific, and North America. The company was founded in 2005 and is based in Xinyu City, t he People?s Republic of China.
Advisors' Opinion:- [By Paul Ausick]
Big Earnings Movers: Tiffany & Co. (NYSE: TIF) is up 8.7% at $88.05 following positive results and a raised outlook. Barnes & Noble Inc. (NYSE: BKS) is down 6% at $15.45 as the bookseller watches its revenue slide. JA Solar Holdings Co. Ltd. (NASDAQ: JASO) is down 10.3% at $XX on a mixed earnings report and LDK Solar Co. Ltd. (NYSE: LDK) is flat at $1.60.
Top 5 Dow Dividend Stocks To Watch Right Now: Theravance Inc.(THRX)
Theravance, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule medicines for various therapeutic areas, including respiratory disease, bacterial infections, and central nervous system (CNS)/pain. The company?s key development programs with GlaxoSmithKline (GSK) include the RELOVAIR, a Phase 3 clinical trial program for the treatment of patients with chronic obstructive pulmonary disease (COPD) and/or asthma; the LAMA/LABA program, a Phase 3 COPD program; and the Bifunctional Muscarinic Antagonist-beta2 Agonist (MABA) program, a Phase 2b program for the treatment of COPD, as well as Peripherally Selective Mu-Opioid Receptor Antagonist (P Advisors' Opinion:
- [By Brian Pacampara]
What: Shares of biopharmaceutical company Theravance (NASDAQ: THRX ) climbed as high as 13% today after announcing plans to split into two companies, separating its drugs under development with GlaxoSmithKline from its other operations.
- [By Sean Williams]
On the bright side, GlaxoSmithKline (NYSE: GSK ) and Theravance (NASDAQ: THRX ) received a much-expected drug approval for once-daily inhaled COPD maintenance treatment Breo Ellipta from the Food and Drug Administration. Having proved non-inferior to the placebo in trials, and delivering a favorable safety profile while reducing flare-ups and helping relieve air flow obstruction, Breo Ellipta has a good shot at being a blockbuster drug within the next couple of years. Breo Ellipta is expected to be available to patients next quarter. In addition, as I've alluded to on numerous occasions, it could be the impetus that encourages Glaxo to gobble up Theravance's Royalty Management -- one of two proposed entities that Theravance plans to split into. This is certainly a big win for both companies.
- [By Jonas Elmerraji]
First up is $4 billion biopharmaceutical firm Theravance (THRX). It's been one heck of a year already for THRX's shareholders. Since the calendar flipped over to January, shares of the firm have rallied more than 75%. But the setup forming in shares points to even higher ground for the final quarter of 2013.
That's because Theravance is currently forming an ascending triangle pattern, a bullish setup that's formed by a horizontal resistance level above shares at $42 and uptrending support to the downside. Basically, as Theravance bounces in between those two technical levels, it's getting squeezed closer and closer to a breakout above that $42 resistance level. When that happens, traders have a buy signal.
Whenever you're looking at any technical price pattern, it's critical to think in terms of those buyers and sellers. Ascending triangles and other pattern names are a good quick way to explain what's going on in a stock, but they're not the reason it's tradable. Instead, it all comes down to supply and demand for shares.
That $42 is a price where there has been an excess of supply of shares; in other words, it's a place where sellers have been more eager to step in and take gains than buyers have been to buy. That's what makes a breakout above it so significant -- the move means that buyers are finally strong enough to absorb all of the excess supply above that price level.
Don't be early on this trade.
- [By Sean Williams]
Perhaps the most exciting new treatment to hit the market in years was recently approved by the FDA. Developed by GlaxoSmithKline (NYSE: GSK ) and Theravance (NASDAQ: THRX ) , Breo Ellipta is a dry powder drug delivered by inhaler and meant to provide long-term relief of air-flow obstruction and reduce COPD exacerbations. The two companies are collaborating on a handful of potentially revolutionary new COPD treatments that combine Theravance's long-acting beta-2 agonists with Glaxo's long-acting muscarinic antagonists. Its next treatment, Breo Anoro, is currently under review by the FDA.
Top 5 Dow Dividend Stocks To Watch Right Now: BOK Financial Corporation(BOKF)
BOK Financial Corporation, a financial holding company, offers a range of financial products and services to commercial and industrial customers, and other financial institutions and consumers. It operates in three segments: Commercial Banking, Consumer Banking, and Wealth Management. The Commercial Banking segment offers lending, treasury, and cash management services; and customer risk management products to small businesses, middle market, and larger commercial customers. The Consumer Banking segment involves in retail lending and deposit services, and mortgage banking activities, as well as offers indirect automobile lending products. The Wealth Management segment provides fiduciary, brokerage and trading, private bank, and investment advisory services. As of December 31, 2010, the company operated 207 consumer banking locations, including branch banking locations and mortgage lending offices; and 1,943 ATM locations. BOK Financial Corporation operates in Oklahoma, Tex as, New Mexico, Northwest Arkansas, Colorado, Arizona, and Kansas/Missouri. The company was founded in 1910 and is headquartered in Tulsa, Oklahoma.
Advisors' Opinion:- [By John Maxfield]
Given that you clicked on this article, it seems safe to assume you either own stock in BOK Financial (NASDAQ: BOKF ) or are considering buying shares in the near future. If so, then you've come to the right place. The table below reveals the nine most critical numbers that investors need to know about BOK (which stands for "Bank of Oklahoma") before deciding whether to buy, sell, or hold its stock.
No comments:
Post a Comment